Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02870478 · ClinicalTrials.gov registry record · Phase 3
The Effects of Low Concentration Atropine on Pupil Size and Accommodation
A Phase 3 study, sponsored by University of California, Berkeley.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
NCT02870478: Completed Phase 3 study, sponsored by University of California, Berkeley.
NCT02870478 is a Phase 3 study that has completed, run by University of California, Berkeley. The registered enrollment target is 32 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02870478, a Phase 3 study, has completed, sponsored by University of California, Berkeley.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.
Interventions
- DRUG Atropine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-11-20 |
| Phase | Phase 3 |
What the finished NCT02870478 record still lists
NCT02870478 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Atropine is the first listed.
NCT02870478 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02870478 about?
NCT02870478 is a clinical study titled "The Effects of Low Concentration Atropine on Pupil Size and Accommodation". The purpose of this study is to determine whether less frequent dosing of atropine drops may be as effective as daily dosing for the treatment of progressive myopia.
What is the current status of trial NCT02870478?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2016-07. Estimated completion is 2019-11-20.
What interventions are being tested in trial NCT02870478?
The interventions under investigation include: Atropine (DRUG).
Who is sponsoring clinical trial NCT02870478?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02870478's enrollment target sits among peer trials
32 1909th of 2000 higher than 87 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia